JPH11509191A - 4,5−ジアリールオキサゾール誘導体 - Google Patents
4,5−ジアリールオキサゾール誘導体Info
- Publication number
- JPH11509191A JPH11509191A JP9504319A JP50431997A JPH11509191A JP H11509191 A JPH11509191 A JP H11509191A JP 9504319 A JP9504319 A JP 9504319A JP 50431997 A JP50431997 A JP 50431997A JP H11509191 A JPH11509191 A JP H11509191A
- Authority
- JP
- Japan
- Prior art keywords
- nmr
- diphenyloxazol
- cdcl
- salt
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000003839 salts Chemical class 0.000 claims abstract description 57
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 37
- 125000001424 substituent group Chemical group 0.000 claims abstract description 37
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 28
- 125000003118 aryl group Chemical group 0.000 claims abstract description 21
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 16
- 239000001257 hydrogen Substances 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 9
- -1 4,5-diphenyloxazole- 2-yl Chemical group 0.000 claims description 250
- 238000004519 manufacturing process Methods 0.000 claims description 185
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 130
- 239000000203 mixture Substances 0.000 claims description 112
- 150000001875 compounds Chemical class 0.000 claims description 108
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 64
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 47
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 36
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 17
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 claims description 17
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 15
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 14
- 159000000000 sodium salts Chemical class 0.000 claims description 13
- 125000002252 acyl group Chemical group 0.000 claims description 12
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 12
- 125000006239 protecting group Chemical group 0.000 claims description 12
- 150000001336 alkenes Chemical class 0.000 claims description 11
- 238000006722 reduction reaction Methods 0.000 claims description 11
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 10
- 125000005037 alkyl phenyl group Chemical group 0.000 claims description 10
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims description 10
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 8
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 claims description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 238000003379 elimination reaction Methods 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- ZXIJMRYMVAMXQP-UHFFFAOYSA-N cycloheptene Chemical compound C1CCC=CCC1 ZXIJMRYMVAMXQP-UHFFFAOYSA-N 0.000 claims description 6
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical compound C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 claims description 6
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 208000031104 Arterial Occlusive disease Diseases 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 208000021328 arterial occlusion Diseases 0.000 claims description 4
- 239000000556 agonist Substances 0.000 claims description 3
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 3
- 238000007887 coronary angioplasty Methods 0.000 claims description 3
- 208000031225 myocardial ischemia Diseases 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 208000037803 restenosis Diseases 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 125000004043 oxo group Chemical group O=* 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 260
- 239000002904 solvent Substances 0.000 description 161
- 239000000243 solution Substances 0.000 description 136
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 119
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 93
- 239000012044 organic layer Substances 0.000 description 77
- 238000003756 stirring Methods 0.000 description 69
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 239000012267 brine Substances 0.000 description 60
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 59
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 58
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 50
- 238000010898 silica gel chromatography Methods 0.000 description 48
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 47
- 229920006395 saturated elastomer Polymers 0.000 description 45
- 238000001035 drying Methods 0.000 description 44
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 39
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
- 239000011780 sodium chloride Substances 0.000 description 34
- 238000006243 chemical reaction Methods 0.000 description 33
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 31
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 31
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 28
- 239000012298 atmosphere Substances 0.000 description 25
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 24
- 239000011734 sodium Substances 0.000 description 24
- 239000010410 layer Substances 0.000 description 19
- 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 17
- 239000011541 reaction mixture Substances 0.000 description 17
- 235000011054 acetic acid Nutrition 0.000 description 16
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 15
- 238000004587 chromatography analysis Methods 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 150000002148 esters Chemical group 0.000 description 14
- 239000000460 chlorine Substances 0.000 description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 12
- 239000004305 biphenyl Substances 0.000 description 11
- 238000001816 cooling Methods 0.000 description 11
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 11
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 11
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 229910052763 palladium Inorganic materials 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 150000002391 heterocyclic compounds Chemical class 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 9
- ODKHOKLXMBWVOQ-UHFFFAOYSA-N 4,5-diphenyl-1,3-oxazole Chemical compound O1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 ODKHOKLXMBWVOQ-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 125000005907 alkyl ester group Chemical group 0.000 description 8
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- GUQOHHIQDGLQSR-UHFFFAOYSA-N 4,5-diphenyl-2-pyrrolidin-2-yl-1,3-oxazole Chemical compound C1CCNC1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)O1 GUQOHHIQDGLQSR-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 6
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000001632 sodium acetate Substances 0.000 description 6
- 235000017281 sodium acetate Nutrition 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 5
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 125000001589 carboacyl group Chemical group 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N cycloheptane Chemical compound C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- LBEGPYVXJUNEKO-UHFFFAOYSA-N (1-butyl-3,4-dihydro-2H-naphthalen-1-yl)oxy-diphenylsilane Chemical group C(CCC)C1(CCCC2=CC=CC=C12)O[SiH](C1=CC=CC=C1)C1=CC=CC=C1 LBEGPYVXJUNEKO-UHFFFAOYSA-N 0.000 description 3
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical group C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 description 3
- QYCGBAJADAGLLK-UHFFFAOYSA-N 1-(cyclohepten-1-yl)cycloheptene Chemical compound C1CCCCC=C1C1=CCCCCC1 QYCGBAJADAGLLK-UHFFFAOYSA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- MVWFPJCRUALBMA-UHFFFAOYSA-N 2-(bromomethyl)-4,5-diphenyl-1,3-oxazole Chemical compound O1C(CBr)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 MVWFPJCRUALBMA-UHFFFAOYSA-N 0.000 description 3
- FAVLBTOVCMFZTG-UHFFFAOYSA-N 5-[tert-butyl(diphenyl)silyl]oxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound C=1C=CC=2C(=O)CCCC=2C=1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 FAVLBTOVCMFZTG-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 244000028419 Styrax benzoin Species 0.000 description 3
- 235000000126 Styrax benzoin Nutrition 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 235000008411 Sumatra benzointree Nutrition 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 3
- 229960002130 benzoin Drugs 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 235000019382 gum benzoic Nutrition 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- 229940102396 methyl bromide Drugs 0.000 description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 3
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 3
- OUNBFDLEIWGWND-UHFFFAOYSA-N n-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl]-4-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound C1CC=2C(OC)=CC=CC=2C1NCC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OUNBFDLEIWGWND-UHFFFAOYSA-N 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 210000004623 platelet-rich plasma Anatomy 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- WGAACZAFJWCWRO-UHFFFAOYSA-N 1-(3-phenylmethoxybenzoyl)piperidine-2-carboxylic acid Chemical compound OC(=O)C1CCCCN1C(=O)C1=CC=CC(OCC=2C=CC=CC=2)=C1 WGAACZAFJWCWRO-UHFFFAOYSA-N 0.000 description 2
- OFUVPHMSTLCRHQ-UHFFFAOYSA-N 1-(4,5-diphenyl-1,3-oxazol-2-yl)ethanamine Chemical compound O1C(C(N)C)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFUVPHMSTLCRHQ-UHFFFAOYSA-N 0.000 description 2
- FSNSOIRVTRIDGK-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]piperidin-1-ium-2-carboxylate Chemical compound COC1=CC=CC(CN2C(CCCC2)C(O)=O)=C1 FSNSOIRVTRIDGK-UHFFFAOYSA-N 0.000 description 2
- MYMSJFSOOQERIO-UHFFFAOYSA-N 1-bromodecane Chemical compound CCCCCCCCCCBr MYMSJFSOOQERIO-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- NQMUGNMMFTYOHK-UHFFFAOYSA-N 1-methoxynaphthalene Chemical compound C1=CC=C2C(OC)=CC=CC2=C1 NQMUGNMMFTYOHK-UHFFFAOYSA-N 0.000 description 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 2
- SYNVKRDWHHMHNM-UHFFFAOYSA-N 2-(2,3-dihydro-1h-inden-4-yloxy)acetic acid Chemical compound OC(=O)COC1=CC=CC2=C1CCC2 SYNVKRDWHHMHNM-UHFFFAOYSA-N 0.000 description 2
- ZLTIOGLTLCOWJI-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydronaphthalen-1-yloxy)acetic acid Chemical compound C1CCCC2=C1C=CC=C2OCC(=O)O ZLTIOGLTLCOWJI-UHFFFAOYSA-N 0.000 description 2
- RQKSHDRDXUQUBA-AWEZNQCLSA-N 2-[(2s)-oxiran-2-yl]-4,5-diphenyl-1,3-oxazole Chemical compound C1O[C@@H]1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)O1 RQKSHDRDXUQUBA-AWEZNQCLSA-N 0.000 description 2
- GWUUTEAWQLWLNN-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]cycloheptan-1-one Chemical compound COC1=CC=CC(CC2C(CCCCC2)=O)=C1 GWUUTEAWQLWLNN-UHFFFAOYSA-N 0.000 description 2
- KXFIYFSPUZSIFV-UHFFFAOYSA-N 2-ethenyl-4,5-diphenyl-1,3-oxazole Chemical compound O1C(C=C)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 KXFIYFSPUZSIFV-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- 125000006291 3-hydroxybenzyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(=C1[H])C([H])([H])* 0.000 description 2
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- JMXMRMSUOHVHOF-UHFFFAOYSA-N 4-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound COC1=CC=CC2=C1CCC2N JMXMRMSUOHVHOF-UHFFFAOYSA-N 0.000 description 2
- DMAWGBBQRFHKPP-UHFFFAOYSA-N 5-(4,5-diphenyl-1,3-oxazol-2-yl)-1-[(3-hydroxyphenyl)methyl]pyrrolidin-2-one Chemical compound OC1=CC=CC(CN2C(CCC2C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 DMAWGBBQRFHKPP-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- MREJFXUHGQYMHI-UHFFFAOYSA-N [2-(4,5-diphenyl-1,3-oxazol-2-yl)piperidin-1-yl]-(3-hydroxyphenyl)methanone Chemical compound OC1=CC=CC(C(=O)N2C(CCCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 MREJFXUHGQYMHI-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CTVMTCPMZHIXPJ-HSZRJFAPSA-N benzyl n-[(1r)-1-(4,5-diphenyl-1,3-oxazol-2-yl)-4-hydroxybutyl]carbamate Chemical compound N([C@H](CCCO)C=1OC(=C(N=1)C=1C=CC=CC=1)C=1C=CC=CC=1)C(=O)OCC1=CC=CC=C1 CTVMTCPMZHIXPJ-HSZRJFAPSA-N 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 125000006309 butyl amino group Chemical group 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- IIRFCWANHMSDCG-UHFFFAOYSA-N cyclooctanone Chemical compound O=C1CCCCCCC1 IIRFCWANHMSDCG-UHFFFAOYSA-N 0.000 description 2
- 239000004913 cyclooctene Substances 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Chemical compound CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- OPGQCFCUJBUTDV-UHFFFAOYSA-N ethyl 1-[(3-methoxyphenyl)methyl]piperidine-2-carboxylate Chemical compound CCOC(=O)C1CCCCN1CC1=CC=CC(OC)=C1 OPGQCFCUJBUTDV-UHFFFAOYSA-N 0.000 description 2
- FGQCYQBPCJMPCS-UHFFFAOYSA-N ethyl 2-[3-(bromomethyl)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CBr)=C1 FGQCYQBPCJMPCS-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- YKUCHDXIBAQWSF-UHFFFAOYSA-N methyl 3-hydroxybenzoate Chemical compound COC(=O)C1=CC=CC(O)=C1 YKUCHDXIBAQWSF-UHFFFAOYSA-N 0.000 description 2
- VQEGUSMZKSIFJC-UHFFFAOYSA-N methyl 3-phenylmethoxybenzoate Chemical compound COC(=O)C1=CC=CC(OCC=2C=CC=CC=2)=C1 VQEGUSMZKSIFJC-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- RCLVLXRXDJVTAP-UHFFFAOYSA-N n-benzyl-5-[tert-butyl(diphenyl)silyl]oxy-1,2,3,4-tetrahydronaphthalen-2-amine Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC(C=1CC2)=CC=CC=1CC2NCC1=CC=CC=C1 RCLVLXRXDJVTAP-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 229960004319 trichloroacetic acid Drugs 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 230000000304 vasodilatating effect Effects 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MAJXEJNHIUFEPX-XMMPIXPASA-N (1r)-5-[tert-butyl(diphenyl)silyl]oxy-1,2,3,4-tetrahydronaphthalen-1-ol Chemical compound C([C@@H](O)C=1C=CC=2)CCC=1C=2O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 MAJXEJNHIUFEPX-XMMPIXPASA-N 0.000 description 1
- UXFHNQVNXIHOAB-AWEZNQCLSA-N (1s)-1-(4,5-diphenyl-1,3-oxazol-2-yl)ethane-1,2-diol Chemical compound O1C([C@@H](O)CO)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 UXFHNQVNXIHOAB-AWEZNQCLSA-N 0.000 description 1
- MAJXEJNHIUFEPX-DEOSSOPVSA-N (1s)-5-[tert-butyl(diphenyl)silyl]oxy-1,2,3,4-tetrahydronaphthalen-1-ol Chemical compound C([C@H](O)C=1C=CC=2)CCC=1C=2O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 MAJXEJNHIUFEPX-DEOSSOPVSA-N 0.000 description 1
- JXGVXCZADZNAMJ-LLVKDONJSA-N (2r)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCCN1C(=O)OCC1=CC=CC=C1 JXGVXCZADZNAMJ-LLVKDONJSA-N 0.000 description 1
- KUWZKOYIJYIQJH-MRXNPFEDSA-N (4r)-4-amino-4-(4,5-diphenyl-1,3-oxazol-2-yl)butan-1-ol Chemical compound O1C([C@@H](CCCO)N)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 KUWZKOYIJYIQJH-MRXNPFEDSA-N 0.000 description 1
- NCLQXWBMORABLL-OAHLLOKOSA-N (5r)-5-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-2-one Chemical compound N1C(=O)CC[C@@H]1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)O1 NCLQXWBMORABLL-OAHLLOKOSA-N 0.000 description 1
- JPJGNZQDELRZGE-UHFFFAOYSA-N (phenyl-$l^{2}-phosphanyl)benzene Chemical compound C=1C=CC=CC=1[P]C1=CC=CC=C1 JPJGNZQDELRZGE-UHFFFAOYSA-N 0.000 description 1
- VMKAFJQFKBASMU-QGZVFWFLSA-N (r)-2-methyl-cbs-oxazaborolidine Chemical compound C([C@@H]12)CCN1B(C)OC2(C=1C=CC=CC=1)C1=CC=CC=C1 VMKAFJQFKBASMU-QGZVFWFLSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- SRNYUVWQHSQIBD-UHFFFAOYSA-N 1-(4,5-diphenyl-1,3-oxazol-2-yl)-2-[(3-methoxyphenyl)methyl]cycloheptan-1-ol Chemical compound COC1=CC=CC(CC2C(CCCCC2)(O)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 SRNYUVWQHSQIBD-UHFFFAOYSA-N 0.000 description 1
- KNDZLAUZLZWHER-UHFFFAOYSA-N 1-(4,5-diphenyl-1,3-oxazol-2-yl)-2-[(3-methoxyphenyl)methyl]cyclooctan-1-ol Chemical compound COC1=CC=CC(CC2C(CCCCCC2)(O)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 KNDZLAUZLZWHER-UHFFFAOYSA-N 0.000 description 1
- PQYIURNANIHDGL-UHFFFAOYSA-N 1-(4,5-diphenyl-1,3-oxazol-2-yl)-4-hydroxybutan-1-one Chemical compound O1C(C(=O)CCCO)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PQYIURNANIHDGL-UHFFFAOYSA-N 0.000 description 1
- GYUJTKRJWWYKBZ-UHFFFAOYSA-N 1-(4,5-diphenyl-1,3-oxazol-2-yl)butane-1,4-diol Chemical compound O1C(C(O)CCCO)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 GYUJTKRJWWYKBZ-UHFFFAOYSA-N 0.000 description 1
- VGISFWWEOGVMED-UHFFFAOYSA-N 1-(chloromethyl)-3-methoxybenzene Chemical compound COC1=CC=CC(CCl)=C1 VGISFWWEOGVMED-UHFFFAOYSA-N 0.000 description 1
- RREMEJOFYABVDK-UHFFFAOYSA-N 1-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl-methylamino]-2,3-dihydro-1h-inden-4-ol Chemical compound C1CC(C(=CC=C2)O)=C2C1N(C)CC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 RREMEJOFYABVDK-UHFFFAOYSA-N 0.000 description 1
- RWQAOEXKISYLFN-UHFFFAOYSA-N 1-azido-5-methoxy-1,2,3,4-tetrahydronaphthalene Chemical compound [N-]=[N+]=NC1CCCC2=C1C=CC=C2OC RWQAOEXKISYLFN-UHFFFAOYSA-N 0.000 description 1
- ZWUNPBJRZHGSPD-UHFFFAOYSA-N 1-butyl-2-phenoxybenzene Chemical group CCCCC1=CC=CC=C1OC1=CC=CC=C1 ZWUNPBJRZHGSPD-UHFFFAOYSA-N 0.000 description 1
- ORLCYMQZIPSODD-UHFFFAOYSA-N 1-chloro-2-[chloro(2,2,2-trichloroethoxy)phosphoryl]oxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(=O)OCC(Cl)(Cl)Cl ORLCYMQZIPSODD-UHFFFAOYSA-N 0.000 description 1
- MLRVZFYXUZQSRU-UHFFFAOYSA-N 1-chlorohexane Chemical compound CCCCCCCl MLRVZFYXUZQSRU-UHFFFAOYSA-N 0.000 description 1
- IBRIMMDNSPFZMB-UHFFFAOYSA-N 1-methoxy-1,2,3,4-tetrahydronaphthalene Chemical compound C1=CC=C2C(OC)CCCC2=C1 IBRIMMDNSPFZMB-UHFFFAOYSA-N 0.000 description 1
- OBYJBIQMQYGWLC-UHFFFAOYSA-N 2,2,3-tributyl-3-methylheptanoic acid Chemical compound C(CCC)C(C(C(=O)O)(CCCC)CCCC)(C)CCCC OBYJBIQMQYGWLC-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- AMOYMEBHYUTMKJ-UHFFFAOYSA-N 2-(2-phenylethoxy)ethylbenzene Chemical compound C=1C=CC=CC=1CCOCCC1=CC=CC=C1 AMOYMEBHYUTMKJ-UHFFFAOYSA-N 0.000 description 1
- IGEUFZLJFZUPBQ-UHFFFAOYSA-N 2-(4,5-diphenyl-1,3-oxazol-2-yl)-3,4-dihydro-2h-pyrrol-5-amine Chemical compound N1C(=N)CCC1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)O1 IGEUFZLJFZUPBQ-UHFFFAOYSA-N 0.000 description 1
- IQXZJNBWFCMKHY-UHFFFAOYSA-N 2-(4,5-diphenyl-1,3-oxazol-2-yl)ethanamine Chemical compound O1C(CCN)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 IQXZJNBWFCMKHY-UHFFFAOYSA-N 0.000 description 1
- GCSGSBFMZMOGEO-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methyl]cyclohexan-1-one Chemical compound COC1=CC=CC=C1CC1C(=O)CCCC1 GCSGSBFMZMOGEO-UHFFFAOYSA-N 0.000 description 1
- ADHXFOIASGNBOC-UHFFFAOYSA-N 2-[(3-methoxy-2-methylphenyl)methyl]cyclohexan-1-one Chemical compound COC1=CC=CC(CC2C(CCCC2)=O)=C1C ADHXFOIASGNBOC-UHFFFAOYSA-N 0.000 description 1
- YGASWNFIIXGECK-UHFFFAOYSA-N 2-[(3-methoxy-4-methylphenyl)methyl]cyclohexan-1-one Chemical compound C1=C(C)C(OC)=CC(CC2C(CCCC2)=O)=C1 YGASWNFIIXGECK-UHFFFAOYSA-N 0.000 description 1
- DFCPMCZUJHQPHF-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]bicyclo[2.2.1]heptan-3-one Chemical compound COC1=CC=CC(CC2C(C3CCC2C3)=O)=C1 DFCPMCZUJHQPHF-UHFFFAOYSA-N 0.000 description 1
- AELKVKOYPRQQMA-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]cyclooctan-1-one Chemical compound COC1=CC=CC(CC2C(CCCCCC2)=O)=C1 AELKVKOYPRQQMA-UHFFFAOYSA-N 0.000 description 1
- ODNDRBROKDCUDE-UHFFFAOYSA-N 2-[(5-methoxy-2-methylphenyl)methyl]cyclohexan-1-one Chemical compound COC1=CC=C(C)C(CC2C(CCCC2)=O)=C1 ODNDRBROKDCUDE-UHFFFAOYSA-N 0.000 description 1
- MMVFXXKSUCXVFK-UHFFFAOYSA-N 2-[(5-methoxy-2-phenylphenyl)methyl]cyclohexan-1-one Chemical compound C=1C(OC)=CC=C(C=2C=CC=CC=2)C=1CC1CCCCC1=O MMVFXXKSUCXVFK-UHFFFAOYSA-N 0.000 description 1
- CDSIASBCDICLDF-UHFFFAOYSA-N 2-[1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)piperidin-2-yl]-4,5-diphenyl-1,3-oxazole Chemical compound C1CC=2C(OC)=CC=CC=2C1N1CCCCC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 CDSIASBCDICLDF-UHFFFAOYSA-N 0.000 description 1
- DNLCNPXSDWFHJM-UHFFFAOYSA-N 2-[1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)pyrrolidin-2-yl]-4,5-diphenyl-1,3-oxazole Chemical compound C1CC=2C(OC)=CC=CC=2C1N1CCCC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 DNLCNPXSDWFHJM-UHFFFAOYSA-N 0.000 description 1
- GXLOTNDOZWGBRX-UHFFFAOYSA-N 2-[1-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidin-2-yl]-4,5-diphenyl-1,3-oxazole Chemical compound C1CCC=2C(OC)=CC=CC=2C1N1CCCC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 GXLOTNDOZWGBRX-UHFFFAOYSA-N 0.000 description 1
- KRUCSCQHLINIOT-UHFFFAOYSA-N 2-[1-benzyl-3-[(3-methoxyphenyl)methyl]pyrrolidin-2-yl]-4,5-diphenyl-1,3-oxazole Chemical compound COC1=CC=CC(CC2C(N(CC=3C=CC=CC=3)CC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 KRUCSCQHLINIOT-UHFFFAOYSA-N 0.000 description 1
- BEHWCNCNVNNNCE-UHFFFAOYSA-N 2-[3-[[2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-3-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(CC2C(NCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BEHWCNCNVNNNCE-UHFFFAOYSA-N 0.000 description 1
- NJGSPUCEBDZTDB-UHFFFAOYSA-N 2-[5-[tert-butyl(diphenyl)silyl]oxy-3,4-dihydronaphthalen-1-yl]-1-(4,5-diphenyl-1,3-oxazol-2-yl)butane-1,4-diol Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC(C=1CCC=2)=CC=CC=1C=2C(CCO)C(O)C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 NJGSPUCEBDZTDB-UHFFFAOYSA-N 0.000 description 1
- NCIQCJFUCONVNO-UHFFFAOYSA-N 2-[6-[(5-methoxy-2-phenylphenyl)methyl]cyclohexen-1-yl]-4,5-diphenyl-1,3-oxazole Chemical compound C=1C(OC)=CC=C(C=2C=CC=CC=2)C=1CC1CCCC=C1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 NCIQCJFUCONVNO-UHFFFAOYSA-N 0.000 description 1
- UWDGGBIFJLRSMR-UHFFFAOYSA-N 2-[7-[(3-methoxyphenyl)methyl]cyclohepten-1-yl]-4,5-diphenyl-1,3-oxazole Chemical compound COC1=CC=CC(CC2C(=CCCCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 UWDGGBIFJLRSMR-UHFFFAOYSA-N 0.000 description 1
- SIQIMUDBCOWFDU-UHFFFAOYSA-N 2-[8-[(3-methoxyphenyl)methyl]cycloocten-1-yl]-4,5-diphenyl-1,3-oxazole Chemical compound COC1=CC=CC(CC2C(=CCCCCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 SIQIMUDBCOWFDU-UHFFFAOYSA-N 0.000 description 1
- RIEYXRPBTRTFGV-UHFFFAOYSA-N 2-[[5-[2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetic acid Chemical compound C1CCC=2C(OCC(=O)O)=CC=CC=2C1N1CCCC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 RIEYXRPBTRTFGV-UHFFFAOYSA-N 0.000 description 1
- DABOPQYORITSKY-UHFFFAOYSA-N 2-[hydroxy-(3-methoxyphenyl)methyl]bicyclo[2.2.1]heptan-3-one Chemical compound COC1=CC=CC(C(O)C2C(C3CCC2C3)=O)=C1 DABOPQYORITSKY-UHFFFAOYSA-N 0.000 description 1
- KDPBUSBZMFZYFU-UHFFFAOYSA-N 2-[hydroxy-(3-methoxyphenyl)methyl]cycloheptan-1-one Chemical compound COC1=CC=CC(C(O)C2C(CCCCC2)=O)=C1 KDPBUSBZMFZYFU-UHFFFAOYSA-N 0.000 description 1
- ZNVXZPKQVGDRBL-UHFFFAOYSA-N 2-[hydroxy-(3-methoxyphenyl)methyl]cyclooctan-1-one Chemical compound COC1=CC=CC(C(O)C2C(CCCCCC2)=O)=C1 ZNVXZPKQVGDRBL-UHFFFAOYSA-N 0.000 description 1
- RGHQKFQZGLKBCF-UHFFFAOYSA-N 2-bromoethyl acetate Chemical compound CC(=O)OCCBr RGHQKFQZGLKBCF-UHFFFAOYSA-N 0.000 description 1
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- GJHFAHVMZHRUFR-UHFFFAOYSA-N 3,4-dimethylpyridin-2-amine Chemical compound CC1=CC=NC(N)=C1C GJHFAHVMZHRUFR-UHFFFAOYSA-N 0.000 description 1
- DXXHRZUOTPMGEH-UHFFFAOYSA-N 3-(1,3-dioxoisoindol-2-yl)propanoic acid Chemical compound C1=CC=C2C(=O)N(CCC(=O)O)C(=O)C2=C1 DXXHRZUOTPMGEH-UHFFFAOYSA-N 0.000 description 1
- LLULYXGGMQPPLI-UHFFFAOYSA-N 3-(4,5-diphenyl-1,3-oxazol-2-yl)-2-[(3-methoxyphenyl)methyl]bicyclo[2.2.1]heptan-3-ol Chemical compound COC1=CC=CC(CC2C(C3CCC2C3)(O)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 LLULYXGGMQPPLI-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- NIGANXKHAUYDCE-UHFFFAOYSA-N 3-[(3-methoxyphenyl)methyl]oxolan-2-one Chemical compound COC1=CC=CC(CC2C(OCC2)=O)=C1 NIGANXKHAUYDCE-UHFFFAOYSA-N 0.000 description 1
- FMRSZFAHCFEHMC-UHFFFAOYSA-N 3-[3-[tert-butyl(diphenyl)silyl]oxyphenyl]-1-(4,5-diphenyl-1,3-oxazol-2-yl)propan-1-one Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC(C=1)=CC=CC=1CCC(=O)C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 FMRSZFAHCFEHMC-UHFFFAOYSA-N 0.000 description 1
- OMESQVYUMXQWFK-UHFFFAOYSA-N 3-[[2-(4,5-diphenyl-1,3-oxazol-2-yl)-5-iminopyrrolidin-1-yl]methyl]phenol Chemical compound OC1=CC=CC(CN2C(CCC2C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N)=C1 OMESQVYUMXQWFK-UHFFFAOYSA-N 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- OKVJCVWFVRATSG-UHFFFAOYSA-N 3-hydroxybenzyl alcohol Chemical compound OCC1=CC=CC(O)=C1 OKVJCVWFVRATSG-UHFFFAOYSA-N 0.000 description 1
- CISXCTKEQYOZAM-UHFFFAOYSA-N 3-phenylmethoxybenzoic acid Chemical compound OC(=O)C1=CC=CC(OCC=2C=CC=CC=2)=C1 CISXCTKEQYOZAM-UHFFFAOYSA-N 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- GUQOHHIQDGLQSR-MRXNPFEDSA-N 4,5-diphenyl-2-[(2r)-pyrrolidin-2-yl]-1,3-oxazole Chemical compound C1CCN[C@H]1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)O1 GUQOHHIQDGLQSR-MRXNPFEDSA-N 0.000 description 1
- GUQOHHIQDGLQSR-INIZCTEOSA-N 4,5-diphenyl-2-[(2s)-pyrrolidin-2-yl]-1,3-oxazole Chemical compound C1CCN[C@@H]1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)O1 GUQOHHIQDGLQSR-INIZCTEOSA-N 0.000 description 1
- VMQAFEQHRVIXPR-UHFFFAOYSA-N 4-(4,5-diphenyl-1,3-oxazol-2-yl)-4-[(4-methoxy-2,3-dihydro-1h-inden-1-yl)amino]butan-1-ol Chemical compound C1CC=2C(OC)=CC=CC=2C1NC(CCCO)C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 VMQAFEQHRVIXPR-UHFFFAOYSA-N 0.000 description 1
- BKULTMWWUHQOOK-UHFFFAOYSA-N 4-[[3-[tert-butyl(diphenyl)silyl]oxyphenyl]methyl]-5-(4,5-diphenyl-1,3-oxazol-2-yl)oxolan-2-one Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC(C=1)=CC=CC=1CC1CC(=O)OC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 BKULTMWWUHQOOK-UHFFFAOYSA-N 0.000 description 1
- BTYSYELHQDGJAB-UHFFFAOYSA-N 4-methoxy-2,3-dihydroinden-1-one Chemical compound COC1=CC=CC2=C1CCC2=O BTYSYELHQDGJAB-UHFFFAOYSA-N 0.000 description 1
- PQPUZCLGQCPJPP-UHFFFAOYSA-N 4-methoxy-n-methyl-2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C(OC)C2=C1C(NC)CC2 PQPUZCLGQCPJPP-UHFFFAOYSA-N 0.000 description 1
- GSYIGWHBQBBXKE-UHFFFAOYSA-N 5-(4,5-diphenyl-1,3-oxazol-2-yl)-1-[(3-methoxyphenyl)methyl]pyrrolidin-2-imine Chemical compound COC1=CC=CC(CN2C(CCC2C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N)=C1 GSYIGWHBQBBXKE-UHFFFAOYSA-N 0.000 description 1
- XSIYGIOLHGZPGV-UHFFFAOYSA-N 5-(4,5-diphenyl-1,3-oxazol-2-yl)-1-[(3-methoxyphenyl)methyl]pyrrolidin-2-one Chemical compound COC1=CC=CC(CN2C(CCC2C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 XSIYGIOLHGZPGV-UHFFFAOYSA-N 0.000 description 1
- SKGCTHQKJFGRPI-UHFFFAOYSA-N 5-[2-(4,5-diphenyl-1,3-oxazol-2-yl)ethylamino]-5,6,7,8-tetrahydronaphthalen-1-ol Chemical compound C1CCC=2C(O)=CC=CC=2C1NCCC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 SKGCTHQKJFGRPI-UHFFFAOYSA-N 0.000 description 1
- CVABDSALDWIYRV-UHFFFAOYSA-N 5-[tert-butyl(diphenyl)silyl]oxy-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C=1C=CC=2C(N)CCCC=2C=1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 CVABDSALDWIYRV-UHFFFAOYSA-N 0.000 description 1
- SOTDESKSPNZKAS-UHFFFAOYSA-N 5-[tert-butyl(diphenyl)silyl]oxy-1,2,3,4-tetrahydronaphthalen-2-amine Chemical compound C=1C=CC=2CC(N)CCC=2C=1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 SOTDESKSPNZKAS-UHFFFAOYSA-N 0.000 description 1
- WAAFTRBGRCYSFD-UHFFFAOYSA-N 5-amino-3,4-dihydropyrrol-2-one Chemical compound NC1=NC(=O)CC1 WAAFTRBGRCYSFD-UHFFFAOYSA-N 0.000 description 1
- WGLJGXBRZQHFBR-UHFFFAOYSA-N 5-methoxy-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound NC1CCCC2=C1C=CC=C2OC WGLJGXBRZQHFBR-UHFFFAOYSA-N 0.000 description 1
- OXXFHUMKHSSUNG-UHFFFAOYSA-N 5-methoxy-1,2,3,4-tetrahydronaphthalene Chemical compound C1CCCC2=C1C=CC=C2OC OXXFHUMKHSSUNG-UHFFFAOYSA-N 0.000 description 1
- BRCPWISABURVIH-UHFFFAOYSA-N 5-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound O=C1CCCC2=C1C=CC=C2OC BRCPWISABURVIH-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N 5-oxo-D-proline Chemical compound OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FTEIPIBCTQWYOL-WBCKFURZSA-N C1(=CC=CC=C1)C=1N=C(OC1C1=CC=CC=C1)[C@@]1(CCCC2=C(C=CC=C12)O[Si](C1=CC=CC=C1)(C1=CC=CC=C1)C(C)(C)C)OC Chemical compound C1(=CC=CC=C1)C=1N=C(OC1C1=CC=CC=C1)[C@@]1(CCCC2=C(C=CC=C12)O[Si](C1=CC=CC=C1)(C1=CC=CC=C1)C(C)(C)C)OC FTEIPIBCTQWYOL-WBCKFURZSA-N 0.000 description 1
- ALRJJKHBCMOTTC-SSEXGKCCSA-N C1(=CC=CC=C1)C=1N=C(OC1C1=CC=CC=C1)[C@]1(CCCC2=C(C=CC=C12)OCC(=O)OCC)NC Chemical compound C1(=CC=CC=C1)C=1N=C(OC1C1=CC=CC=C1)[C@]1(CCCC2=C(C=CC=C12)OCC(=O)OCC)NC ALRJJKHBCMOTTC-SSEXGKCCSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical group O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- UJKVCLAXSZDPQZ-UHFFFAOYSA-M N=C(CC1)N(CC2=CC(OCC([O-])=O)=CC=C2)C1C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)O1.[Na+] Chemical compound N=C(CC1)N(CC2=CC(OCC([O-])=O)=CC=C2)C1C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)O1.[Na+] UJKVCLAXSZDPQZ-UHFFFAOYSA-M 0.000 description 1
- 240000007019 Oxalis corniculata Species 0.000 description 1
- 235000016499 Oxalis corniculata Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 150000001218 Thorium Chemical class 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 241001504505 Troglodytes troglodytes Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- SJQGRSYYHYIOKH-DEOSSOPVSA-N [(1s)-5-[tert-butyl(diphenyl)silyl]oxy-1,2,3,4-tetrahydronaphthalen-1-yl]-diazonioazanide Chemical compound C([C@@H](C=1C=CC=2)[N-][N+]#N)CCC=1C=2O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 SJQGRSYYHYIOKH-DEOSSOPVSA-N 0.000 description 1
- LPHKUSMVIDPYHQ-UHFFFAOYSA-N [Na].C1CC2CCC1C2 Chemical compound [Na].C1CC2CCC1C2 LPHKUSMVIDPYHQ-UHFFFAOYSA-N 0.000 description 1
- BDKZHNJTLHOSDW-UHFFFAOYSA-N [Na].CC(O)=O Chemical compound [Na].CC(O)=O BDKZHNJTLHOSDW-UHFFFAOYSA-N 0.000 description 1
- GADCSXYERCAYQK-UHFFFAOYSA-M [O-]C(COC1=CC=CC(C(N(CCCC2)C2C2=NC(C3=CC=CC=C3)=C(C3=CC=CC=C3)O2)=O)=C1)=O.[Na+] Chemical compound [O-]C(COC1=CC=CC(C(N(CCCC2)C2C2=NC(C3=CC=CC=C3)=C(C3=CC=CC=C3)O2)=O)=C1)=O.[Na+] GADCSXYERCAYQK-UHFFFAOYSA-M 0.000 description 1
- PBCPCTYGZJIHAU-UHFFFAOYSA-M [O-]C(COC1=CC=CC(CN(C(CC2)C3=NC(C4=CC=CC=C4)=C(C4=CC=CC=C4)O3)C2=O)=C1)=O.[Na+] Chemical compound [O-]C(COC1=CC=CC(CN(C(CC2)C3=NC(C4=CC=CC=C4)=C(C4=CC=CC=C4)O3)C2=O)=C1)=O.[Na+] PBCPCTYGZJIHAU-UHFFFAOYSA-M 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052977 alkali metal sulfide Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000004791 alkyl magnesium halides Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000002257 antimetastatic agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 150000007860 aryl ester derivatives Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- RSEPHCRIRACQML-UHFFFAOYSA-N benzyl piperidine-2-carboxylate Chemical compound C1CCCNC1C(=O)OCC1=CC=CC=C1 RSEPHCRIRACQML-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- PCDHSSHKDZYLLI-UHFFFAOYSA-N butan-1-one Chemical compound CCC[C]=O PCDHSSHKDZYLLI-UHFFFAOYSA-N 0.000 description 1
- NOSOEJSZWOKISI-UHFFFAOYSA-N butane-1,4-dione Chemical compound O=[C]CC[C]=O NOSOEJSZWOKISI-UHFFFAOYSA-N 0.000 description 1
- MNSBLWANOCYPMT-UHFFFAOYSA-N butyl(diphenyl)silane Chemical group C=1C=CC=CC=1[SiH](CCCC)C1=CC=CC=C1 MNSBLWANOCYPMT-UHFFFAOYSA-N 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-O butylazanium Chemical compound CCCC[NH3+] HQABUPZFAYXKJW-UHFFFAOYSA-O 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- URYYVOIYTNXXBN-UPHRSURJSA-N cyclooctene Chemical compound C1CCC\C=C/CC1 URYYVOIYTNXXBN-UPHRSURJSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- USLKCMBGQFYUFI-UHFFFAOYSA-N dichloromethane;tribromoborane Chemical compound ClCCl.BrB(Br)Br USLKCMBGQFYUFI-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- XOZRYYLBZXGSOU-UHFFFAOYSA-N ethyl 2-[(1-hydroxy-2,3-dihydro-1h-inden-4-yl)oxy]acetate Chemical compound CCOC(=O)COC1=CC=CC2=C1CCC2O XOZRYYLBZXGSOU-UHFFFAOYSA-N 0.000 description 1
- DFFRTNMMPGOXDB-UHFFFAOYSA-N ethyl 2-[3-(hydroxymethyl)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CO)=C1 DFFRTNMMPGOXDB-UHFFFAOYSA-N 0.000 description 1
- PUJLDNHQSLSRAC-UHFFFAOYSA-N ethyl 2-[3-(pyrrolidin-1-ylmethyl)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CN2CCCC2)=C1 PUJLDNHQSLSRAC-UHFFFAOYSA-N 0.000 description 1
- DAJVSFINNPRNLS-UHFFFAOYSA-N ethyl 2-[3-[2-(4,5-diphenyl-1,3-oxazol-2-yl)piperidine-1-carbonyl]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(C(=O)N2C(CCCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 DAJVSFINNPRNLS-UHFFFAOYSA-N 0.000 description 1
- OSOCVIUOXLDOKN-UHFFFAOYSA-N ethyl 2-[3-[2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidine-1-carbonyl]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(C(=O)N2C(CCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 OSOCVIUOXLDOKN-UHFFFAOYSA-N 0.000 description 1
- IOXNBXXRGDOBLY-AREMUKBSSA-N ethyl 2-[3-[[(2r)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]methyl]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CN2[C@H](CCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 IOXNBXXRGDOBLY-AREMUKBSSA-N 0.000 description 1
- IOXNBXXRGDOBLY-SANMLTNESA-N ethyl 2-[3-[[(2s)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]methyl]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CN2[C@@H](CCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 IOXNBXXRGDOBLY-SANMLTNESA-N 0.000 description 1
- XBGRHHWFBGESJV-UHFFFAOYSA-N ethyl 2-[3-[[2-(4,5-diphenyl-1,3-oxazol-2-yl)cyclooct-2-en-1-yl]methyl]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CC2C(=CCCCCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 XBGRHHWFBGESJV-UHFFFAOYSA-N 0.000 description 1
- IPCJUPUHAOEZCJ-UHFFFAOYSA-N ethyl 2-[3-[[2-(4,5-diphenyl-1,3-oxazol-2-yl)thiolan-3-yl]methyl]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(CC2C(SCC2)C=2OC(=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 IPCJUPUHAOEZCJ-UHFFFAOYSA-N 0.000 description 1
- AYVGEWFWWZDGBQ-IZLXSDGUSA-N ethyl 2-[[(5r)-5-[(2s)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound O1C([C@@H]2CCCN2[C@H]2C=3C=CC=C(C=3CCC2)OCC(=O)OCC)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 AYVGEWFWWZDGBQ-IZLXSDGUSA-N 0.000 description 1
- AYVGEWFWWZDGBQ-WUFINQPMSA-N ethyl 2-[[(5s)-5-[(2r)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound O1C([C@H]2CCCN2[C@@H]2C=3C=CC=C(C=3CCC2)OCC(=O)OCC)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 AYVGEWFWWZDGBQ-WUFINQPMSA-N 0.000 description 1
- AYVGEWFWWZDGBQ-NSOVKSMOSA-N ethyl 2-[[(5s)-5-[(2s)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound O1C([C@@H]2CCCN2[C@@H]2C=3C=CC=C(C=3CCC2)OCC(=O)OCC)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 AYVGEWFWWZDGBQ-NSOVKSMOSA-N 0.000 description 1
- YEOWYGLHXQDCDM-UHFFFAOYSA-N ethyl 2-[[1-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl-formylamino]-2,3-dihydro-1h-inden-4-yl]oxy]acetate Chemical compound C1CC=2C(OCC(=O)OCC)=CC=CC=2C1N(C=O)CC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 YEOWYGLHXQDCDM-UHFFFAOYSA-N 0.000 description 1
- SNPXZKKDOIHENG-UHFFFAOYSA-N ethyl 2-[[1-[(4,5-diphenyl-1,3-oxazol-2-yl)methylamino]-2,3-dihydro-1h-inden-4-yl]oxy]acetate Chemical compound C1CC=2C(OCC(=O)OCC)=CC=CC=2C1NCC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 SNPXZKKDOIHENG-UHFFFAOYSA-N 0.000 description 1
- HSFZDNORWYVKSN-UHFFFAOYSA-N ethyl 2-[[1-[(4,5-diphenyl-1,3-oxazol-2-yl)methylsulfanyl]-2,3-dihydro-1h-inden-4-yl]oxy]acetate Chemical compound C1CC=2C(OCC(=O)OCC)=CC=CC=2C1SCC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 HSFZDNORWYVKSN-UHFFFAOYSA-N 0.000 description 1
- AKIJMMCOVZRGCM-UHFFFAOYSA-N ethyl 2-[[1-[acetyl-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl]amino]-2,3-dihydro-1h-inden-4-yl]oxy]acetate Chemical compound C1CC=2C(OCC(=O)OCC)=CC=CC=2C1N(C(C)=O)CC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 AKIJMMCOVZRGCM-UHFFFAOYSA-N 0.000 description 1
- UHVSUWTWJAIMMW-UHFFFAOYSA-N ethyl 2-[[5-[1-(4,5-diphenyl-1,3-oxazol-2-yl)ethyl-methylamino]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound C1CCC=2C(OCC(=O)OCC)=CC=CC=2C1N(C)C(C)C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 UHVSUWTWJAIMMW-UHFFFAOYSA-N 0.000 description 1
- PMXWPNZTNQGSFJ-UHFFFAOYSA-N ethyl 2-[[5-[1-(4,5-diphenyl-1,3-oxazol-2-yl)ethylamino]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound C1CCC=2C(OCC(=O)OCC)=CC=CC=2C1NC(C)C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PMXWPNZTNQGSFJ-UHFFFAOYSA-N 0.000 description 1
- OZHQBPXRBOADPJ-UHFFFAOYSA-N ethyl 2-[[5-[2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-6-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound OC1CCC=2C(OCC(=O)OCC)=CC=CC=2C1N1CCCC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OZHQBPXRBOADPJ-UHFFFAOYSA-N 0.000 description 1
- KZBXAKSXADJVRU-UHFFFAOYSA-N ethyl 2-[[5-[[1-(4,5-diphenyl-1,3-oxazol-2-yl)-3-hydroxypropyl]amino]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound C1CCC=2C(OCC(=O)OCC)=CC=CC=2C1NC(CCO)C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 KZBXAKSXADJVRU-UHFFFAOYSA-N 0.000 description 1
- LSRZWALHMHTZJU-UHFFFAOYSA-N ethyl 3-[3-[(2-oxocyclohexyl)methyl]phenyl]prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=CC(CC2C(CCCC2)=O)=C1 LSRZWALHMHTZJU-UHFFFAOYSA-N 0.000 description 1
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- SZIKRGHFZTYTIT-UHFFFAOYSA-N ethyl piperidine-2-carboxylate Chemical compound CCOC(=O)C1CCCCN1 SZIKRGHFZTYTIT-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- RFVVKQJBAVGVOB-UHFFFAOYSA-N methyl 2-[(5-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]acetate Chemical compound OC1CCCC2=C1C=CC=C2OCC(=O)OC RFVVKQJBAVGVOB-UHFFFAOYSA-N 0.000 description 1
- ISKKNAFDZHWLSG-UHFFFAOYSA-N methyl 2-[[6-[(4,5-diphenyl-1,3-oxazol-2-yl)methylamino]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate Chemical compound C1CC=2C(OCC(=O)OC)=CC=CC=2CC1NCC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 ISKKNAFDZHWLSG-UHFFFAOYSA-N 0.000 description 1
- 229940120152 methyl 3-hydroxybenzoate Drugs 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- BVWNNXMFSCNABT-UHFFFAOYSA-N n-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl]-n-(4-methoxy-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C(C)=O)CC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 BVWNNXMFSCNABT-UHFFFAOYSA-N 0.000 description 1
- ZUDUADHFYJZDMZ-UHFFFAOYSA-N n-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl]-n-ethyl-4-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound C1CC(C(=CC=C2)OC)=C2C1N(CC)CC(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 ZUDUADHFYJZDMZ-UHFFFAOYSA-N 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000162 organ preservation solution Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229910003445 palladium oxide Inorganic materials 0.000 description 1
- JQPTYAILLJKUCY-UHFFFAOYSA-N palladium(ii) oxide Chemical compound [O-2].[Pd+2] JQPTYAILLJKUCY-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- KZVLNAGYSAKYMG-UHFFFAOYSA-N pyridine-2-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=N1 KZVLNAGYSAKYMG-UHFFFAOYSA-N 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000011182 sodium carbonates Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YFAOXJSHGWODRD-UHFFFAOYSA-N tert-butyl-[3-[[2-(4,5-diphenyl-1,3-oxazol-2-yl)thiolan-3-yl]methyl]phenoxy]-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC(C=1)=CC=CC=1CC1CCSC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 YFAOXJSHGWODRD-UHFFFAOYSA-N 0.000 description 1
- ZUVYGUWCSNVEJT-UHFFFAOYSA-N tert-butyl-[[5-[2-(4,5-diphenyl-1,3-oxazol-2-yl)oxolan-3-yl]-7,8-dihydronaphthalen-1-yl]oxy]-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC(C=1CCC=2)=CC=CC=1C=2C1CCOC1C(O1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 ZUVYGUWCSNVEJT-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式 [式中、R1はカルボキシまたは保護されたカルボキシ、 R2は適当な置換基を有していてもよいアリール、 R3は適当な置換基を有していてもよいアリール、 R4は水素、低級アルキル、ヒドロキシまたはアリール、 A1は低級アルキレン、 アルケン、シクロ(C7−C8)アルカン、ビシクロヘプタン、ビ シクロヘプテン、テトラヒドロフラン、テトラヒドロチオフェン、アゼチジン、 ピロリジンまたはピペリジンを示し、その各々は適当な置換基を有していてもよ い。)、または (式中、R5は水素、低級アルキルまたはアシルを 示す。)、 A6は適当な置換基を有していてもよい低級アルキレンを示す。 ]、 nは0または1、 をそれぞれ意味する。]で表される化合物および医薬として許容されるその塩。 2.R2がフェニルまたは低級アルキルフェニル、 R3がフェニルまたは低級アルキルフェニル、 R4が水素、低級アルキル、ヒドロキシまたはフェニル、 アルケン、シクロ(C7−C8)アルカン、ビシクロヘプタン、ビ シクロヘプテン、テトラヒドロフラン、テトラヒドロチオフェン、アゼチジン、 ピロリジンまたはピペリジンを示し、その各々はイミノ、オキソ、アシルおよび イミノ保護基からなる群より選ばれる1ないし3個の適当な置換基を有していて もよい。)、または (式中、R5は水素、低級アルキルまたはアシルを 示す。)、 A6は、低級アルキルおよびヒドロキシ(低級)アルキルからな る群より選ばれる1ないし3個の適当な置換基を有していてもよい低級アルキレ ンを示す。]、 である請求項1に記載の化合物。 アルケン、シクロ(C7−C8)アルカン、ビシクロ[2.2.1 ]ヘプタン、ビシクロ[2.2.1]ヘプテン、テトラヒドロフラン、テトラヒ ドロチオフェン、アゼチジン、ピロリジンまたはピペリジンを示し、その各々は イミノ、オキソ、低級アルカノイルおよびモノ(またはジまたはトリ)フェニル (低級)アルキルからなる群より選ばれる1または2個の適当な置換基を有して いてもよい。)、または (式中、R5は水素、低級アルキルまたは低級ア ルカノイル)、 A6は、低級アルキルおよびヒドロキシ(低級)アルキルからな る群より選ばれる1個の適当な置換基を有していてもよい低級アルキレンを示す 。]、 である請求項2に記載の化合物。 4.R1がカルボキシまたはエステル化されたカルボキシ、 アルケン、シクロ(C7−C8)アルカン、ビシクロ[2.2.1 ]ヘプタン、ビシクロ[2.2.1]ヘプト−2−エン、テトラヒドロフラン、 テトラヒドロチオフェン、アゼチジン、ピロリジンまたはピペリジンを示し、そ の各々はイミノ、オキソ、低級アルカノイルおよびフェニル(低級)アルキルか らなる群より選 ばれる1または2個の適当な置換基を有していてもよい。)、または (式中、R5は水素、低級アルキルまたは低級ア ルカノイル)、 A6は、低級アルキルおよびヒドロキシ(低級)アルキルからな る群より選ばれる1個の適当な置換基を有していてもよい低級アルキレンを示す 。]、 である請求項3に記載の化合物。 5.R1がカルボキシまたは低級アルコキシカルボニル、 R2がフェニルまたはC1−C4アルキルフェニル、 R3がフェニルまたはC1−C4アルキルフェニル、 R4が水素、C1−C4アルキル、ヒドロキシまたはフェニル、 A1がC1−C4アルキレン、 アルケン、シクロ(C7−C8)アルカン、ビシクロ[2.2.1 ]ヘプタン、ビシクロ[2.2.1]ヘプト−2−エン、テトラヒドロフラン、 テトラヒドロチオフェン、アゼチジン、ピロリジンまたはピペリジンを示し、そ の各々はイミノ、オキソ、C1−C4アルカノイルおよびフェニル(C1−C4)ア ルキルからなる群より選ばれる1または2個の適当な置換基を有していてもよい 。)、または (式中、R5は水素、C1−C4アルキルまたはC1 −C4アルカノイル)、 A6は、C1−C4アルキルおよびヒドロキシ(C1−C4)アルキ ルからなる群より選ばれる1個の適当な置換基を有していてもよいC1−C4アル キレンを示す。]、 である請求項4に記載の化合物。 6.式 [式中、R1はカルボキシまたは保護されたカルボキシ、 R2はフェニルまたは低級アルキルフェニル、 R3はフェニルまたは低級アルキルフェニル、 A1は低級アルキレン、 をそれぞれ意味する。]で表される化合物または医薬として許容されるその塩で ある請求項1に記載の化合物。 7.(1) (1R)−1−[(2R)−2−(4,5−ジフェニルオキサゾ ール−2−イル)ピロリジン−1−イル]−5−カルボキシメトキシ−1,2, 3,4−テトラヒドロナフタレンのナトリウム塩および (2) (1S)−1−[(2S)−2−(4,5−ジフェニルオキサゾール− 2−イル)ピロリジン−1−イル]−5−カルボキシメトキシ−1,2,3,4 −テトラヒドロナフタレンのナトリウム塩 からなる群より選ばれる請求項6に記載の化合物。 8.式 [式中、R1はカルボキシまたは保護されたカルボキシ、 R2はフェニルまたは低級アルキルフェニル、 R3はフェニルまたは低級アルキルフェニル、 A1は低級アルキレン、 をそれぞれ意味する。]で表される化合物または医薬として許容されるその塩で ある請求項1に記載の化合物。 9.(1) [3−[[(2R)−2−(4,5−ジフェニルオキサゾール− 2−イル)ピロリジン−1−イル]メチル]フェノキシ]酢酸ナトリウムおよび (2) [3−[[(2S)−2−(4,5−ジフェニルオキサゾール−2−イ ル)ピロリジン−1−イル]メチル]フェノキシ]酢酸ナトリウム からなる群より選ばれる請求項8に記載の化合物。 10.式 [式中、R1はカルボキシまたは保護されたカルボキシ、 R2は適当な置換基を有していてもよいアリール、 R3は適当な置換基を有していてもよいアリール、 R4は水素、低級アルキル、ヒドロキシまたはアリール、 A1は低級アルキレン、 アルケン、シクロ(C7−C8)アルカン、ビシクロヘプタン、ビ シクロヘプテン、テトラヒドロフラン、テトラヒドロチオフェン、アゼチジン、 ピロリジンまたはピペリジンを示し、その各々は適当な置換基を有していてもよ い。)、または (式中、R5は水素、低級アルキルまたはアシル を示す。)、 A6は適当な置換基を有していてもよい低級アルキレンを示す。 ]、 nは0または1、 をそれぞれ意味する。]で表される化合物またはその塩の製造法であって、 (1)式 である。) で表される化合物またはその塩を、式 Y1−A1−R1 (式中、R1およびA1はそれぞれ前記定義の通りであり、 Y1は酸残基を意味する。) で表される化合物またはその塩と反応させて、式 記定義の通りである。) で表される化合物またはその塩を得るか、または (2)式 定義の通りであり、 を意味する。) で表される化合物またはその塩を、カルボキシ保護基の脱離反応に付して、式 定義の通りである。) で表される化合物またはその塩を得るか、または (3)式 れ前記定義の通りである。) で表される化合物またはその塩を酸化反応に付して、式 れ前記定義の通りである。) で表される化合物またはその塩を得るか、または (4)式 れ前記定義の通りであり、 R6はイミノ保護基、 を意味する。) で表される化合物またはその塩を、イミノ保護基の脱離反応に付して、式 れ前記定義の通りである。) で表される化合物またはその塩を得るか、または (5)式 れ前記定義の通りであり、 を意味する。) で表される化合物またはその塩を、還元反応に付して、式 れ前記定義の通りであり、 を意味する。) で表される化合物またはその塩を得るか、または (6)式 通りであり、 Y2はハロゲン、 を意味する。) で表される化合物またはその塩を、式 (式中、R2およびR3はそれぞれ前記定義の通りである。) で表される化合物またはその塩と反応させて、式 れ前記定義の通りである。) で表される化合物またはその塩を得ることを特徴とする前記製造法。 11.医薬として許容される担体とともに請求項1に記載の化合物または医薬と して許容されるその塩を有効成分として含有する医薬組成物。 12.請求項1に記載の化合物または医薬として許容されるその塩の、プロスタ グランジンI2アゴニストとしての用途。 13.請求項1に記載の化合物または医薬として許容されるその塩をヒトまたは 動物に投与することからなる動脈閉塞症、経皮経管冠動脈形成後の再狭窄、動脈 硬化、脳血管障害または虚血性心疾患の治療または予防方法。 14.請求項1に記載の化合物または医薬として許容されるその塩を、医薬とし て許容される担体と混合することからなる医薬組成物の製造方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9515085.0A GB9515085D0 (en) | 1995-07-21 | 1995-07-21 | Heterocyclic compounds |
AU9002 | 1996-03-29 | ||
AUPN9002A AUPN900296A0 (en) | 1996-03-29 | 1996-03-29 | Heterocyclic compounds |
AU9515085.0 | 1996-03-29 | ||
PCT/JP1996/001996 WO1997003973A1 (en) | 1995-07-21 | 1996-07-18 | 4,5-diaryl oxazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11509191A true JPH11509191A (ja) | 1999-08-17 |
Family
ID=25645150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9504319A Ceased JPH11509191A (ja) | 1995-07-21 | 1996-07-18 | 4,5−ジアリールオキサゾール誘導体 |
Country Status (17)
Country | Link |
---|---|
US (2) | US5972965A (ja) |
EP (2) | EP1213285A3 (ja) |
JP (1) | JPH11509191A (ja) |
KR (1) | KR19990063582A (ja) |
CN (1) | CN1095839C (ja) |
AT (1) | ATE224380T1 (ja) |
AU (1) | AU716304B2 (ja) |
CA (1) | CA2227442A1 (ja) |
DE (1) | DE69623785T2 (ja) |
DK (1) | DK0842161T3 (ja) |
EA (1) | EA002156B1 (ja) |
ES (1) | ES2181902T3 (ja) |
HU (1) | HUP9900881A3 (ja) |
MX (1) | MX9800577A (ja) |
PT (1) | PT842161E (ja) |
TW (1) | TW401408B (ja) |
WO (1) | WO1997003973A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002085850A1 (fr) * | 2001-04-19 | 2002-10-31 | Eisai Co., Ltd. | Derives d'amidine cyclique |
JPWO2003074483A1 (ja) * | 2002-03-05 | 2005-06-30 | 小野薬品工業株式会社 | 8−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤 |
US7375236B2 (en) | 2003-02-19 | 2008-05-20 | Eisai Co., Ltd. | Methods for producing cyclic benzamidine derivatives |
JP2013534254A (ja) * | 2010-08-20 | 2013-09-02 | アラーガン インコーポレイテッド | 複数のプロスタグランジン受容体に作用し、一般的な抗炎症反応を生じる化合物 |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO713297A0 (en) | 1997-06-02 | 1997-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compound |
GB9720270D0 (en) | 1997-09-25 | 1997-11-26 | Pharmagene Lab Limited | Medicaments for the treatment of migraine |
AUPP003297A0 (en) | 1997-10-27 | 1997-11-20 | Fujisawa Pharmaceutical Co., Ltd. | 4,5-diaryloxazole compounds |
AUPP029197A0 (en) | 1997-11-10 | 1997-12-04 | Fujisawa Pharmaceutical Co., Ltd. | Benzocycloheptene derivatives |
AUPP109097A0 (en) | 1997-12-22 | 1998-01-22 | Fujisawa Pharmaceutical Co., Ltd. | Napthalene derivatives |
DE19801648A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | alpha-Substituierte Lactone |
GB9804426D0 (en) | 1998-03-02 | 1998-04-29 | Pfizer Ltd | Heterocycles |
AUPP608898A0 (en) * | 1998-09-23 | 1998-10-15 | Fujisawa Pharmaceutical Co., Ltd. | New use of prostaglandin E2 antagonists |
US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
US6335459B1 (en) | 1998-12-23 | 2002-01-01 | Syntex (U.S.A.) Llc | Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators |
ES2232434T3 (es) | 1999-03-05 | 2005-06-01 | Duke University | Analogos de prostaglandinas c-16 fp selectivas insaturadas. |
CA2377593A1 (en) * | 1999-06-21 | 2000-12-28 | Fujisawa Pharmaceutical Co., Ltd. | Remedies for skin ulcer |
US6894175B1 (en) * | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
AUPQ253199A0 (en) | 1999-08-30 | 1999-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Non-prostanoid prostaglandin I2-agonist |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
WO2002085412A1 (fr) * | 2001-04-18 | 2002-10-31 | Fujisawa Pharmaceutical Co., Ltd. | Inhibiteurs de la fibrose des tissus |
AU2003214525B2 (en) | 2002-04-12 | 2008-09-25 | Pfizer Inc. | Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
KR100468352B1 (ko) * | 2002-09-24 | 2005-01-27 | 한국과학기술연구원 | 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물 |
PL377848A1 (pl) | 2003-02-07 | 2006-02-20 | Daiichi Pharmaceutical Co., Ltd. | Pochodne pirazoli |
US7557095B2 (en) * | 2006-05-12 | 2009-07-07 | Allergan, Inc. | Therapeutic compounds |
CA2730599C (en) | 2008-07-23 | 2016-09-13 | Toray Industries, Inc. | Therapeutic agent for chronic renal failure |
RU2509768C2 (ru) * | 2008-09-10 | 2014-03-20 | Асахи Гласс Компани, Лимитед | Новое производное простагландина i2 |
US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
WO2011111714A1 (ja) * | 2010-03-08 | 2011-09-15 | 科研製薬株式会社 | 新規なep4アゴニスト |
NZ704799A (en) | 2012-08-24 | 2018-06-29 | Univ Texas | Heterocyclic modulators of hif activity for treatment of disease |
EP2888256A4 (en) * | 2012-08-24 | 2016-02-17 | Univ Texas | HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES |
US9115120B2 (en) * | 2012-08-24 | 2015-08-25 | Board Of Regents, The University Of Texas Systems | Heterocyclic modulators of HIF activity for treatment of disease |
DK3110420T3 (da) | 2014-02-25 | 2019-05-13 | Board Of Regents Univ Of Texas System | Salte af heterocykliske modulatorer af hif-aktivitet til behandling af sygdomme |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ236474A (en) * | 1989-12-20 | 1993-07-27 | Bristol Myers Squibb Co | 4,5-diphenyl-2-oxazole octanoic, nonanoic and decanoic acid and ester derivatives, preparation and pharmaceutical compositions thereof |
US5348969A (en) * | 1992-04-03 | 1994-09-20 | Bristol-Myers Squibb Company | Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors |
US5187188A (en) * | 1992-04-03 | 1993-02-16 | Bristol-Myers Squibb Company | Oxazole carboxylic acid derivatives |
US5362879A (en) * | 1993-04-15 | 1994-11-08 | Bristol-Myers Squibb Company | 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation |
HUT76341A (en) * | 1993-12-20 | 1997-08-28 | Fujisawa Pharmaceutical Co | Process for preparation of 4,5-diaryloxazole derivatives and pharmaceutical compositions containing them |
KR100383305B1 (ko) | 1994-03-10 | 2003-11-01 | 후지사와 야꾸힝 고교 가부시키가이샤 | 프로스타글란딘i₂작용물질로서의나프탈렌유도체 |
-
1996
- 1996-07-17 TW TW085108673A patent/TW401408B/zh active
- 1996-07-18 CN CN96197084A patent/CN1095839C/zh not_active Expired - Fee Related
- 1996-07-18 JP JP9504319A patent/JPH11509191A/ja not_active Ceased
- 1996-07-18 CA CA002227442A patent/CA2227442A1/en not_active Abandoned
- 1996-07-18 DK DK96924137T patent/DK0842161T3/da active
- 1996-07-18 DE DE69623785T patent/DE69623785T2/de not_active Expired - Fee Related
- 1996-07-18 EP EP02003081A patent/EP1213285A3/en not_active Withdrawn
- 1996-07-18 EP EP96924137A patent/EP0842161B1/en not_active Expired - Lifetime
- 1996-07-18 PT PT96924137T patent/PT842161E/pt unknown
- 1996-07-18 AT AT96924137T patent/ATE224380T1/de not_active IP Right Cessation
- 1996-07-18 US US08/983,139 patent/US5972965A/en not_active Expired - Fee Related
- 1996-07-18 WO PCT/JP1996/001996 patent/WO1997003973A1/en not_active Application Discontinuation
- 1996-07-18 MX MX9800577A patent/MX9800577A/es not_active IP Right Cessation
- 1996-07-18 HU HU9900881A patent/HUP9900881A3/hu unknown
- 1996-07-18 KR KR1019980700438A patent/KR19990063582A/ko not_active Application Discontinuation
- 1996-07-18 ES ES96924137T patent/ES2181902T3/es not_active Expired - Lifetime
- 1996-07-18 AU AU64697/96A patent/AU716304B2/en not_active Ceased
- 1996-07-18 EA EA199800141A patent/EA002156B1/ru not_active IP Right Cessation
-
1999
- 1999-07-20 US US09/357,664 patent/US6300344B1/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002085850A1 (fr) * | 2001-04-19 | 2002-10-31 | Eisai Co., Ltd. | Derives d'amidine cyclique |
US7244730B2 (en) | 2001-04-19 | 2007-07-17 | Eisai Co., Ltd | 2-iminopyrrolidine derivatives |
US7304083B2 (en) | 2001-04-19 | 2007-12-04 | Eisai R&D Management Co., Ltd. | 2-iminoimidazole derivatives (2) |
US7476688B2 (en) | 2001-04-19 | 2009-01-13 | Eisai R&D Management Co., Ltd. | Cyclic amidine derivatives |
JPWO2003074483A1 (ja) * | 2002-03-05 | 2005-06-30 | 小野薬品工業株式会社 | 8−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤 |
US7375236B2 (en) | 2003-02-19 | 2008-05-20 | Eisai Co., Ltd. | Methods for producing cyclic benzamidine derivatives |
JP2013534254A (ja) * | 2010-08-20 | 2013-09-02 | アラーガン インコーポレイテッド | 複数のプロスタグランジン受容体に作用し、一般的な抗炎症反応を生じる化合物 |
Also Published As
Publication number | Publication date |
---|---|
AU6469796A (en) | 1997-02-18 |
EP0842161A1 (en) | 1998-05-20 |
DE69623785D1 (de) | 2002-10-24 |
DE69623785T2 (de) | 2003-08-07 |
PT842161E (pt) | 2003-02-28 |
HUP9900881A3 (en) | 2000-09-28 |
EA002156B1 (ru) | 2001-12-24 |
HUP9900881A2 (hu) | 1999-08-30 |
DK0842161T3 (da) | 2003-01-27 |
MX9800577A (es) | 1998-04-30 |
EP0842161B1 (en) | 2002-09-18 |
TW401408B (en) | 2000-08-11 |
AU716304B2 (en) | 2000-02-24 |
EP1213285A3 (en) | 2002-07-03 |
ATE224380T1 (de) | 2002-10-15 |
CA2227442A1 (en) | 1997-02-06 |
US5972965A (en) | 1999-10-26 |
CN1196726A (zh) | 1998-10-21 |
EP1213285A2 (en) | 2002-06-12 |
ES2181902T3 (es) | 2003-03-01 |
KR19990063582A (ko) | 1999-07-26 |
WO1997003973A1 (en) | 1997-02-06 |
US6300344B1 (en) | 2001-10-09 |
CN1095839C (zh) | 2002-12-11 |
EA199800141A1 (ru) | 1998-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11509191A (ja) | 4,5−ジアリールオキサゾール誘導体 | |
KR100345943B1 (ko) | 4,5-디아릴옥사졸유도체 | |
JP6049791B2 (ja) | ペルオキシソーム増殖剤活性化受容体δの活性化剤 | |
US6133308A (en) | Synthesis of clasto-lactacystin beta-lactone and analogs thereof | |
US6660759B1 (en) | 4.5-diaryloxazole compounds with prostaglandin I2 (PGI2) agonistic activity | |
EP0202164A1 (fr) | Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique | |
CA2301054A1 (en) | Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof | |
JP2001526257A (ja) | ナフタレン誘導体 | |
US6297267B1 (en) | 4,5-diaryloxazole compounds | |
EP1958941A1 (en) | Oxazolidinones and their use as hypocholesterolemic agents | |
JP2001522830A (ja) | ベンゾシクロヘプテン誘導体 | |
FR2523128A1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et medicaments contenant ces derives | |
WO2005116018A1 (fr) | Derives de tyrosine substitues par alcanoyle utiles comme agonistes de hppar$g(a) & hppar$g(g) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20050223 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050520 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071023 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080207 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080507 |